SPL Set ID: f8a26673-261c-4e8e-b1e1-9e23aaf7f285

1 drug(s) with this SPL Set ID

Open DailyMed details

POSACONAZOLE POSACONAZOLE
100 mg Delayed-release
AUROBINDO PHARMA LIMITED FDA Rx Only

Posaconazole is an azole antifungal agent available as delayed-release tablet for oral administration. Posaconazole is designated chemically as 4-[4-[4-[4-[[(3 R ,5 R )-5-(2,4-difluorophenyl)tetrahydro-5-(1 H -1,2,4-triazol-1-ylmethyl)-3-furanyl]methoxy]phenyl]-1-piperazinyl]phenyl]-2-[(1 S ,2 S )-1-ethyl-2-hydroxypropyl]-2,4-dihydro-3 H -1,2,4-triazol-3-one with an molecular formula of C 37 H 42 F 2 N 8 O 4 and a molecular weight of 700.8. The chemical structure is: Posaconazole is a white to off-white crystalline powder with a low aqueous solubility. Posaconazole Delayed-Release Tablets Posaconazole delayed-release tablets are a yellow colored, matt finished, film-coated, oblong shaped tablets containing 100 mg of posaconazole. Each delayed-release tablet contains the inactive ingredients: black iron oxide, colloidal silicon dioxide, croscarmellose sodium, hydroxypropyl cellulose, hypromellose acetate succinate, iron oxide yellow, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol-part. hydrolyzed, talc, and titanium dioxide. str

← Back to search